|
| ||
|
|
||
Actual Cases (actual + case)
Selected AbstractsSimulation-based Morbidity and Mortality Conference: New Technologies Augmenting Traditional Case-based PresentationsACADEMIC EMERGENCY MEDICINE, Issue 1 2006John Vozenilek MD Abstract The authors describe the use of a high-fidelity simulation laboratory to re-create a patient encounter for the purposes of enhancing a morbidity and mortality conference. The use of two separate technologies were enlisted: a METI high-fidelity patient simulator to re-create the case in a more lifelike fashion, and an audience response system to collect clinical impressions throughout the case presentation and survey data at the end of the presentation. The re-creation of the patient encounter with all relevant physical findings displayed in high fidelity, with relevant laboratory data, nursing notes, and imaging as it occurred in the actual case, provides a more engaging format for the resident,learner. This technological enhancement was deployed at a morbidity and mortality conference, and the authors report the impressions collected via the audience response system. Guidelines for those who wish to re-create this type of educational experience are presented in the discussion. [source] Methods to Determine Storativity of Infinite Confined Aquifers from a Recovery TestGROUND WATER, Issue 4 2002Djaouida Chenaf Starting from the equations of Theis and Cooper-Jacob, two new mathematical methods are proposed for interpreting the residual drawdown data for an infinite confined aquifer. Under Theis' assumptions and using the Cooper-Jacob approximation, the principal aquifer characteristics of transmissivity, pumping storativity, and recovery storativity are expressed without any correction or additional assumption. An actual case is used for illustration and confirms the validity of proposed equations and methods. [source] Secondary prevention of ischemic stroke: Challenging patient scenarios,JOURNAL OF HOSPITAL MEDICINE, Issue S4 2008Kiwon Lee MD Abstract The risk for recurrent stroke following a stroke or transient ischemic attack (TIA) is high. Prevention of a secondary event is a priority, as the associated morbidity and mortality are great. Antiplatelet agents have been shown to reduce this risk, but the choice of treatment modality depends on a number of factors, including the underlying cause of the stroke and the patient's comorbidities. For example, a cardioembolic stroke is best treated with anticoagulants, whereas one of noncardioembolic origin requires antiplatelet therapy. A number of challenging patient scenarios are explored in this article, and appropriate medical management is discussed, with the goal of examining the most recent trial data and information in the context of an actual case. Eight sample cases are presented: stroke prevention in a patient with recent stent placement, low ejection fraction, intracranial stenosis, carotid stenosis, atherosclerosis of the aortic arch, symptomatic coronary artery disease, antiplatelet failure, and stroke prevention in a patient already on warfarin. Journal of Hospital Medicine 2008;3(4 Suppl):S20,S28. © 2008 Society of Hospital Medicine. [source] Companies rehearse a very different future: Connecting leadership capability and strategy execution through simulationGLOBAL BUSINESS AND ORGANIZATIONAL EXCELLENCE, Issue 5 2009Ron Carucci How can an organization's leaders best learn the behaviors and competencies required in a very different future? "Rehearsing the future" simulations immerse leaders in a fictitious business context strategically similar to their company's desired future to solve critical issues as a leadership team. The author differentiates future rehearsal simulation from computer simulation; describes when, where, and why these simulations are effective; and details the process for building a simulation that integrates multiple leadership development tools. Two actual cases, a global technology corporation seeking a horizontally integrated platform of products and services and a biotech company determined to shorten its product development timelines, illustrate the benefits of simulation technology for leaders and the business. © 2009 Wiley Periodicals, Inc. [source] A new direction in M&A integration: How companies find solutions to value destruction in people-based activityGLOBAL BUSINESS AND ORGANIZATIONAL EXCELLENCE, Issue 4 2009Ben de Haldevang We've all heard merger-and-acquisition (M&A) horror stories in which ignoring the complex human element in integration led to problems that leached away some,or much,of the deal's hoped-for value. The success stories presented here point to effective strategies for smoothly merging organizations without compromising productivity, talent and customer retention, innovation, and other sources of value creation. The author argues that integration planning and management, which too often focus narrowly on process, should also explicitly address the people-intensive aspects of planning, speed, communication, innovation, culture, and HR issues. For each of these areas, he presents actual cases in which preparation or intervention kept a postdeal integration on track and shares specific solutions and tools that can be adapted to other M&As. © 2009 Wiley Periodicals, Inc. [source] The use of multiple correspondence analysis and hierarchical clustering to identify incident typologies pertaining to the biofuel industryBIOFUELS, BIOPRODUCTS AND BIOREFINING, Issue 1 2010Carine Riviére Abstract Biofuel production has been expanding for more than five years, leading to an increasing number of production sites worldwide and also to a tremendous diversification of processes and approaches to producing biofuel. Such a fast move in industry has sometimes proven in the past to potentially lead to underestimating safety management needs. The significant number of existing facilities producing so called first generation biofuel allows for a reasonable survey of safety issues from incidents. In 2006, INERIS initiated research work devoted to the analysis of safety-related issues including the implementation of an incidents database. Its purpose is to collect known and reasonably well documented incidents (explosions, fires, spills, derailments, and road accidents) that relate to the life cycle of biofuel supply chains. This paper focuses on the analysis of this database, which contains 100 incidents that occurred from January 2000 to early 2009. From the database, an attempt has been made to identify the root factors of incidents potentially impacting biofuel supply chains, using statistical methods like multiple correspondence analysis and ascendant hierarchical clustering. This multivariate analysis exercise has led us to identify five main incident typologies, which in turn allows us to draw appropriate information on safety issues pertaining to first-generation biofuel supply chains. Each typology is illustrated by actual cases of accidents. Copyright © 2009 Society of Chemical Industry and John Wiley & Sons, Ltd [source] Penile epithelioid sarcoma and the case for a histopathological diagnosis in Peyronie's diseaseBJU INTERNATIONAL, Issue 6 2003M.F. Usta Objectives To devise a set of clinical criteria that would identify which penile abnormality could be malignant and warrant biopsy, between Peyronie's disease (a pathological fibrosis involving the tunica albuginea of the penis) and epithelioid sarcoma (ES) of the penis (a rare malignant condition which can resemble Peyronie's disease in clinical presentation). Patients and methods The pathology reports and histological slides of men with Peyronie's disease who underwent penile biopsy were reviewed for ES. The medical charts of suspicious cases were then reviewed by a pathologist, unaware of the origin, for consistencies in signs, symptoms and clinical findings. These consistencies were then to be used to develop criteria for biopsy. Thirty-two men underwent penile biopsy from 1992 to 2001. Results Because there were no actual cases of ES, a specific set of criteria for ES could not be established. A review of previously published cases was then used for comparison with the present patients. Conclusions Many of the previously reported cases included signs and symptoms of urethral narrowing or compression, causing lower urinary tract symptoms. In addition, the penile nodule size was reported to progressively enlarge over time. Because of the high prevalence of Peyronie's disease and low prevalence of ES, biopsy of every penile nodule is not judicious. However, signs and symptoms of urethral obstruction, and a progressively growing and persistently painful nodule should suggest a possible malignancy and warrant biopsy. [source] | ||||||||||